Treatment of Chronic Active Antibody-Mediated Kidney Transplant Rejection With Intravenous Immunoglobulin

被引：0
|
作者：
Rapetskaya, Nadzeya [1 ]
Komissarov, Kirill [2 ]
Kalachyk, Aleh [2 ]
机构：
[1] State Inst Minsk Sci & Pract Ctr Surg Transplanto, Transplant Nephrol, Minsk, BELARUS
[2] State Inst Minsk Sci & Pract Ctr Surg Transplanto, Nephrol, Renal Replacement Trerapy & Kidney Transplantat, Minsk, BELARUS
来源：
TRANSPLANTATION | 2022年 / 106卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P8.049
引用
收藏
页码：S572 / S572
页数：1
相关论文
共 50 条
  • [1] Rituximab and Intravenous Immunoglobulin Treatment of Chronic Antibody-Mediated Kidney Allograft Rejection
    Fehr, Thomas
    Ruesi, Barbara
    Fischer, Andreas
    Hopfer, Helmut
    Wuethrich, Rudolf P.
    Gaspert, Ariana
    TRANSPLANTATION, 2009, 87 (12) : 1837 - 1841
  • [2] Intensive Plasmapheresis and Intravenous Immunoglobulin for Treatment of Antibody-Mediated Rejection After Kidney Transplant
    Ruangkanchanasetr, Prajej
    Satirapoj, Bancha
    Termmathurapoj, Sumeth
    Namkhanisorn, Kesinee
    Suaywan, Kongsak
    Nimkietkajorn, Veerapatr
    Luesutthiviboon, Lersan
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2014, 12 (04) : 328 - 333
  • [3] Treatment of Transplant Glomerulopathy during Chronic Antibody-Mediated Rejection with Intravenous Immunoglobulin and Rituximab
    Bachelet, T.
    Nodimar, C.
    Taupin, J. -L.
    Lepreux, S.
    Moreau, K.
    Morel, D.
    Guidicelli, G.
    Couzi, L.
    Merville, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 413 - 413
  • [4] COMBINATION THERAPY OF RITUXIMAB AND INTRAVENOUS IMMUNOGLOBULIN AS AN EFFECTIVE TREATMENT FOR CHRONIC ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS
    Park, Woo Yeong
    Kang, Seong Sik
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [5] COMBINATION THERAPY OF RITUXIMAB AND INTRAVENOUS IMMUNOGLOBULIN AS AN EFFECTIVE TREATMENT FOR CHRONIC ANTIBODY-MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS
    Park, Woo Yeong
    Yeo, Sang Mok
    Park, Hayeon
    Kang, Seong Sik
    Jin, Kyubok
    Park, Sung Bae
    Han, Seungyeup
    TRANSPLANT INTERNATIONAL, 2017, 30 : 527 - 527
  • [6] Tocilizumab for treatment of chronic active antibody-mediated rejection in kidney transplant recipients
    Boonpheng, Boonphiphop
    De Castro, Iris Camille C.
    Ng, Yue-Harn
    Blosser, Christopher
    Bakthavatsalam, Ramasamy
    Gimferrer, Idoia
    Smith, Kelly
    Leca, Nicolae
    CLINICAL TRANSPLANTATION, 2023, 37 (05)
  • [7] Clinical Outcome of Rituximab and Intravenous Immunoglobulin Combination Therapy in Kidney Transplant Recipients with Chronic Active Antibody-Mediated Rejection
    Ban, Tae Hyun
    Yu, Ji Hyun
    Chung, Byung Ha
    Choi, Bum Soon
    Park, Cheol Whee
    Kim, Yong-Soo
    Yang, Chul Woo
    ANNALS OF TRANSPLANTATION, 2017, 22 : 468 - 474
  • [8] Efficacy of Combined Plasmapheresis and Intravenous Immunoglobulin Therapy in Kidney Transplant Patients With Chronic Antibody-mediated Rejection
    Oguz, Ebru Gok
    Okyay, Gulay Ulusal
    Akoglu, Hadim
    Merhametsiz, Ozgur
    Yildirim, Tolga
    Canbakan, Basol
    Ayli, Mehmet Deniz
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2016, 10 (03) : 151 - 155
  • [9] Effectiveness of Rituximab and Intravenous Immunoglobulin Therapy in Renal Transplant Recipients with Chronic Active Antibody-Mediated Rejection
    Hong, Y. A.
    Kim, H. G.
    Choi, S. R.
    Sun, I. O.
    Park, H. S.
    Chung, B. H.
    Choi, B. S.
    Park, C. W.
    Kim, Y. S.
    Yang, C. W.
    TRANSPLANTATION PROCEEDINGS, 2012, 44 (01) : 182 - 184
  • [10] Mesangiolysis in Chronic Active Antibody-mediated Rejection in Kidney Transplant Biopsies
    Suto, Yuki
    Oguchi, Hideyo
    Tochigi, Naobumi
    Mikami, Tetuo
    Shinoda, Kazunobu
    Honda, Kazuho
    Kounoue, Noriyuki
    Hashimoto, Junya
    Muramatsu, Masaki
    Itabashi, Yoshihiro
    Sakai, Ken
    NEPHRON, 2023, : 14 - 21
12345